Get started
Author

Ken O. Awuondo

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
2008 · Philip Bejon, John Lusingu, et al. · New England Journal of Medicine · 448
PDF
Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria Exposure
2013 · Ally Olotu, Gregory Fegan, et al. · New England Journal of Medicine · 279
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial
2011 · Ally Olotu, John Lusingu, et al. · The Lancet Infectious Diseases · 172
CLSI-Derived Hematology and Biochemistry Reference Intervals for Healthy Adults in Eastern and Southern Africa
2009 · Etienne Karita, Nzeera Ketter, et al. · PLoS ONE · 170
PDF
Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection against Plasmodium falciparum infection in Kenyan adults
2015 · Caroline Ogwang, Domtila Kimani, et al. · Science Translational Medicine · 134
Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial
2016 · James A Berkley, Moses Ngari, et al. · The Lancet Global Health · 133
Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
2014 · Susanne H. Hodgson, Elizabeth Juma, et al. · Frontiers in Microbiology · 116
PDF
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
2021 · David Ishola, Daniela Manno, et al. · The Lancet Infectious Diseases · 99
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
2021 · Muhammed O Afolabi, David Ishola, et al. · The Lancet Infectious Diseases · 97
Age, Spatial, and Temporal Variations in Hospital Admissions with Malaria in Kilifi County, Kenya: A 25-Year Longitudinal Observational Study
2016 · Polycarp Mogeni, Thomas N. Williams, et al. · PLoS Medicine · 89
PDF
Establishing a malaria diagnostics centre of excellence in Kisumu, Kenya
2007 · Colin Ohrt, Peter Obare, et al. · Malaria Journal · 73
PDF
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
2015 · Susanne H Hodgson, Elizabeth Juma, et al. · Malaria Journal · 72
PDF
Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
2018 · Abraham Siika, Leanne McCabe, et al. · Clinical Infectious Diseases · 33
PDF
In Vivo and In Vitro Efficacy of Amodiaquine againstPlasmodium falciparumin an Area of Continued Use of 4‐Aminoquinolines in East Africa
2009 · Philip Sasi, Abdi Abdulrahaman, et al. · The Journal of Infectious Diseases · 33
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial
2018 · Jane Mallewa, Alexander J Szubert, et al. · The Lancet HIV · 31
PDF
Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
2010 · John Lusingu, Ally Olotu, et al. · PLoS ONE · 29
PDF
Long-term cellular immunity of vaccines for Zaire Ebola Virus Diseases
2024 · Aurélie Wiedemann, Edouard Lhomme, et al. · Nature Communications · 25
PDF
Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries
2021 · Moses Badio, Edouard Lhomme, et al. · Trials · 22
PDF
Use of Rapid Diagnostic Tests in Malaria School Surveys in Kenya: Does their Under-performance Matter for Planning Malaria Control?
2012 · Caroline W. Gitonga, Jimmy H. Kihara, et al. · American Journal of Tropical Medicine and Hygiene · 21
Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
2011 · Joyce U Nyiro, Eduard J Sanders, et al. · BMC Infectious Diseases · 21
PDF
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults
2023 · Andrew W Lee, Ken Liu, et al. · Clinical Infectious Diseases · 19
PDF
Clinical laboratory reference values amongst children aged 4 weeks to 17 months in Kilifi, Kenya: A cross sectional observational study
2017 · Jesse Gitaka, Caroline Ogwang, et al. · PLoS ONE · 14
PDF
Temporal Association of Acute Hepatitis A and Plasmodium falciparum Malaria in Children
2011 · Peter Klein Klouwenberg, Philip Sasi, et al. · PLoS ONE · 9
PDF
Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial
2024 · Simon Valayer, Marie Alexandre, et al. · Emerging Microbes & Infections · 6
Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children
2010 · John Lusingu, Ally Olotu, et al. · PLoS ONE · 1
Works count: 26
Citation count: 2,147
H-index: 20
I10-index: 22
Year
Topic
Type